Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

NCT00194740 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Docetaxel
DRUG: Vinorelbine
DRUG: Filgrastim

Sponsor

University of Washington

Collaborators

[object Object]